[New non-benzodiazepine hypnotics. Progress in therapy of sleep disorders?].
Hajak
G
G
Psychiatrische Klinik und Poliklinik, Universität Göttingen.
Rüther
E
E
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D053961:Azabicyclo Compounds; D001569:Benzodiazepines; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000209:etiology / Q000517:prevention & control; D000077334:Zolpidem
D014151:Anti-Anxiety Agents; D053961:Azabicyclo Compounds; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011725:Pyridines; C515050:zopiclone; D001569:Benzodiazepines; D000077334:Zolpidem
Neue Nichtbenzodiazepinhypnotika. Ein Forschritt in der Therapie von Schlafstörungen?